Back to Dashboard










Bayer AG N (BAYN.DE)
Real-time intraday values
Market Overview
From:
To:
BAYN.DE Intraday
No data available
SymbolBAYN.DE
IPO DateDec 16, 1996
CEOMr. William N. Anderson
Full Time Employees87.8k
SectorHealthcare
IndustryDrug Manufacturers - General
CountryGermany
ExchangeXETRA
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | +0.97% | +0.46 US$ |
| 5 Days | +3.23% | +1.49 US$ |
| 1 Month | +1.47% | +0.69 US$ |
| 6 Months | +5.53% | +2.50 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of BAYN.DE...
Key Statistics
Market Cap
46.85B
P/E Ratio
N/A
Div Yield
0.23%
52W High
$53.92
52W Low
$24.80
Analyst Consensus
ConsensusBuy
Bullish1477.8%
Neutral316.7%
Bearish15.6%
52W Analyst Price Targets
Min Target
$46.00
$46.00
Max Target
$65.00
$65.00
Current$47.69
Avg Target$54.92
Community Thoughts
Share your analysis and sentiment on BAYN.DE
Join the community to share your analysis
Latest News for BAYN.DE
Is Spotify Technology (SPOT) Fully Valued Going Into Earnings?
Simply Wall St.•Jul 30, 2026, 03:17 AM
Did AI Momentum and France’s Exit Just Shift Palantir Technologies' (PLTR) Investment Narrative?
Simply Wall St.•Jul 30, 2026, 03:16 AM
AutoNation (AN) Jumps On Strong Returns, Is It Still Undervalued?
Simply Wall St.•Jul 30, 2026, 03:16 AM
Is Yum! Brands (YUM) A Bargain As Leadership Changes Raise Fresh Valuation Questions?
Simply Wall St.•Jul 30, 2026, 03:16 AM
Alphabet (GOOGL) Disbands AlphaFold Team As DeepMind Pushes Gemini Further
Simply Wall St.•Jul 30, 2026, 03:16 AM
Is Astera Labs (ALAB) Fairly Valued As Revenue Growth Hits 115%?
Simply Wall St.•Jul 30, 2026, 03:15 AM
Could Kiniksa Pharmaceuticals International (KNSA) Be 16% Overvalued After Raised 2026 Guidance?
Simply Wall St.•Jul 30, 2026, 03:15 AM
SolarEdge (SEDG) Stock Looks Undervalued Following Its 87% Five Year Slump
Simply Wall St.•Jul 30, 2026, 03:15 AM
Circle (CRCL) Stock Looks Expensive Despite Its 68% One Year Fall
Simply Wall St.•Jul 30, 2026, 03:15 AM
China Daily: Orchid grower cultivates cross-Strait community
PR Newswire•Jul 30, 2026, 03:14 AM